NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Basic Experimental Studies with Humans (BESH) Required)
ID: 355212Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355212

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-218.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the HEAL Initiative PainCare Clinician Training Program (PCTP) through Mentored Clinical Scientist Development Awards (K08) aimed at supporting early-career clinician-scientists in establishing independent research programs focused on pain management. This program emphasizes basic experimental studies involving human participants and seeks to address critical issues such as chronic pain management, health equity, and non-opioid treatment options. Awardees will receive up to $125,000 annually for salary and $50,000 for research-related expenses, with applications evaluated based on candidate potential, career development plans, and scientific merit. Interested applicants should note that the application deadline is July 12, 2027, and can find further details at the provided NIH link or contact grantsinfo@nih.gov for inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-218-Full-Announcement.html
    PAR-24-218.html
    The NIH HEAL Initiative PainCare Clinician Training Program (PCTP) aims to foster the development of early-career clinician-scientists by offering Mentored Clinical Scientist Development Awards (K08). These awards will provide clinical researchers dedicated support to establish independent research programs addressing the complexities of pain management. The program focuses on basic experimental studies involving human participants, supporting projects that study various aspects of pain, including chronic pain management, health equity, and non-opioid treatments. Key eligibility criteria include having a clinical doctoral degree and a commitment of at least 75% effort to research activities. Each application must demonstrate a structured plan for career development and researcher independence, alongside a robust research proposal that emphasizes rigor and transparency. Award budgets include a yearly salary of up to $125,000 and $50,000 in research-related expenses. Applications are evaluated based on candidate potential, career development plans, and the scientific merit of the research proposals. This initiative reflects the NIH's commitment to enhancing the clinical pain research workforce in alignment with addressing public health challenges regarding pain and opioid use. Applications for funding will be reviewed rigorously to cultivate independent research leaders in this critical field.
    Similar Opportunities
    NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative PainCare Clinician Training Program (PCTP) through Mentored Clinical Scientist Development Awards (K08), aimed at supporting early-career clinician-scientists in pain management research. This program seeks to cultivate a cohort of independent investigators who will lead clinical trials, thereby enhancing the clinical pain research workforce to address the ongoing chronic pain and opioid crisis. Awardees will receive substantial salary support of up to $125,000 annually, along with additional funding for research-related expenses, and must demonstrate a strong mentoring structure and commitment to health equity in their research proposals. Interested applicants can find more information and application details at the provided NIH link, with a submission deadline of July 12, 2027, and inquiries directed to grantsinfo@nih.gov.
    NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Basic Experimental Studies with Humans (BESH) Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative PainCare Clinician Training Program (PCTP) through the Mentored Clinical Scientist Development Awards (K08), aimed at supporting early-career clinician-scientists focused on clinical pain research. This program seeks to develop independent investigators who will conduct basic experimental studies involving human participants, with a strong emphasis on innovating treatments for chronic pain, which affects over 25 million Americans. Awardees will receive funding of up to $125,000 per year for salary and an additional $50,000 for research development costs, with a commitment of at least 75% full-time effort required. Interested applicants can find more information and guidance by contacting NIH Grants Information at grantsinfo@nih.gov, and the application deadline is July 12, 2027.
    NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Patient-Oriented Research Career Development award (K23 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative PainCare Clinician Training Program (PCTP), a Mentored Patient-Oriented Research Career Development award (K23), aimed at supporting early-career clinician-scientists in conducting patient-oriented research in pain management. This grant program is designed to cultivate a new cohort of independent researchers capable of leading clinical trials that address chronic pain, a significant health issue affecting over 25 million Americans. Awardees will receive salary support, research expenses, and training in rigorous research methodologies, while also engaging with established mentoring teams and participating in annual networking meetings. The application deadline is July 12, 2027, and interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-220.html.
    HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award, aimed at supporting researchers in the fields of pain and substance use disorder (SUD). This grant program, known as the K99/R00 Career Transition Award, is designed to facilitate the transition of outstanding postdoctoral researchers into independent investigator roles, with a focus on conducting basic experimental studies involving human participants. The initiative is part of NIH's broader strategy to address the opioid epidemic by enhancing research on alternative pain treatments and improving addiction treatment strategies. Interested applicants must be in postdoctoral positions with no more than four years of experience, and the application deadline is March 11, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award (K99/R00) to support postdoctoral researchers transitioning to independent careers in Pain and Substance Use Disorder (SUD) research. This grant program aims to enhance the independent investigator workforce by providing up to five years of funding, divided into a mentored phase lasting up to two years and an independent phase lasting up to three years, specifically designed to address the critical need for innovative solutions in pain management and addiction treatment amid the ongoing opioid crisis. Eligible applicants must be in mentored postdoctoral positions and are encouraged to propose rigorous biomedical research plans, although independent clinical trials are not permitted. Interested candidates should submit their proposals by March 11, 2025, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HEAL Initiative: HEAL KIDS (Knowledge, Innovation and Discovery Studies): Chronic Pain Program (UC2 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative, specifically targeting chronic pain in children and adolescents through the HEAL KIDS Chronic Pain Program. This program invites interdisciplinary research teams to conduct innovative studies that integrate clinical research, advanced technologies, and measurement science to enhance understanding and management of chronic pain conditions in youth. The initiative emphasizes the importance of diversity in research, requiring applicants to submit a Plan for Enhancing Diverse Perspectives, and aims to improve pediatric pain management and facilitate clinical trials. Approximately $5 million is available for 2-3 awards, with a maximum annual budget of $1.3 million over a five-year project period. Interested applicants must submit their proposals by November 8, 2024, and can find additional information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative aimed at supporting research for non-opioid analgesics via the R61/R33 Exploratory/Developmental Phased Award. This initiative encourages applications that focus on the early translational steps in developing novel pain treatment strategies, including the development and validation of assays and the identification of potential therapeutic agents, while explicitly prohibiting clinical trials. The funding amount is up to $350,000 per year, with a total project period not exceeding three years, and applications are due by January 15, 2027. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award (K99/R00) to support the transition of postdoctoral researchers into independent faculty roles in the fields of Pain and Substance Use Disorders (SUD) research. This program aims to enhance workforce diversity by encouraging applications from underrepresented groups and providing funding for basic experimental studies involving human participants. The K99 phase offers up to two years of salary and research support, while the R00 phase provides independent research support for up to three years, contingent upon satisfactory progress. Interested applicants must have no more than four years of postdoctoral experience and are encouraged to apply by the deadline of March 11, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-024.html.
    HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the HEAL Initiative's funding opportunity titled "Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)." This initiative aims to support pilot projects that identify new druggable targets for pain by generating preliminary data on understudied proteins associated with pain management. The funding opportunity is particularly significant as it seeks to advance research in pain management and drug discovery, contributing to the broader goal of addressing the opioid addiction crisis. Eligible applicants can receive up to $100,000 for projects lasting one year, with applications due by July 16, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-197.html.
    HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative, titled "Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)." This initiative aims to support early-stage translational research focused on developing and validating tests for non-opioid analgesics, including small molecules and biologics, to address the ongoing opioid crisis and improve pain management. The program anticipates a funding pool of $2.5 million, with plans to award approximately 4-5 grants in FY 2025, and applications are due by January 15, 2027. Interested applicants can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.